ALXA Financial Facts
Interest and other income/ (expense), net: 115KRevenue: 673K
See Full Income Statement
See Full Balance Sheet
Alexza Pharmaceuticals Inc. (ALXA) Earnings
|
Expand Research on ALXA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +40.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -9.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/14/13 | Q113 | -$1.31 | -$0.45 | -$0.86 | $729K | $1M | N/A |  | | Details | |
| 8/8/13 | Q213 | -$0.21 | $0.09 | -$0.30 | $40.84M | $14.17M | N/A | | | Details | |
11/6/13  |
 |
Q313 | -$0.72 | -$0.54 | -$0.18 | $2.2M | $1.98M | N/A | | | Details |
| 5/11/16 |
|
Q116 | -$0.16 | N/A | N/A | N/A | N/A | N/A | | | Details |
| 11/7/11 |
|
Q311 | -$0.19 | -$0.14 | -$0.05 | $1.3M | $670K | N/A | | | Details |
| 8/6/15 |
|
Q215 | -$0.63 | -$0.60 | -$0.03 | N/A | $1.49M | N/A | | | Details |
| 11/30/-1 | Q411 | -$0.13 | -$0.12 | -$0.01 | $1.88M | $5.8M | N/A | | | Details | |
| 8/8/11 |
|
Q211 | -$0.13 | -$0.15 | +$0.02 | $1.26M | $430K | N/A | | | Details |
